LON:SLN - Silence Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
GBX 49.95 -1.05 (-2.06 %)
(As of 03/19/2019 11:22 AM ET)
Previous CloseGBX 51
Today's RangeGBX 49 - GBX 49.95
52-Week RangeGBX 46.10 - GBX 202
Volume7,289 shs
Average Volume13,380 shs
Market Capitalization£35.50 million
P/E Ratio-7.35
Dividend YieldN/A
BetaN/A

Analyst Ratings

Silence Therapeutics (LON:SLN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Silence Therapeutics in the last 12 months. Their average twelve-month price target is GBX 277The high price target for SLN is GBX 277 and the low price target for SLN is GBX 277. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 277GBX 277GBX 277GBX 277

Silence Therapeutics (LON:SLN) Consensus Price Target History

Price Target History for Silence Therapeutics (LON:SLN)

Silence Therapeutics (LON:SLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
3/11/2019Peel HuntReiterated RatingUnder ReviewView Rating Details
(Data available from 3/19/2017 forward)
This page was last updated on 3/19/2019 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel